This hottest twist inside the Lykos Therapeutics saga threatens a major overhaul of the company’s method and way, with Musk ally and billionaire Trader Antonio Gracias appearing to wish to take the organization back toward its nonprofit drug development roots and a more Doblinite philosophy.The meals allergy application was submitted from the exp